Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success! Not sure where to start with intellectual property...

* This is an online event that will take place 1200–1300 UK time (1300-1400 CET) on Zoom. * REMEDi4ALL is presenting to the TAR Network in a Proven Connect webinar....

From Hypothesis to Impact: Navigating the Repurposing Pathway Drug repurposing represents a vital pathway for treatment development, both for patient communities and academic innovators. Finding new uses for existing drugs can provide a more rapid pathway to...

REMEDi4ALL Funders Network Meets Policy   Event Summary This event has already taken place. Thank you to everyone who attended the Funders Network meeting. Read the event summary to learn...

Join iDR26, the International Drug Repurposing Conference, on 12-13 May 2026 in Brussels, Belgium to explore the future of patient-centric medicines repurposing.   From rare diseases and AI-driven drug discovery, to policy, funding and community-led success stories, iDR26 brings together the global drug repurposing...

Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation Webinar description BioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar...

An introduction to HTA, Early HTA, and patient preference evidence for demonstrating the value of repurposed medicines. Repurposing has the potential to bring treatments to patients more quickly and efficiently....

Are you an early career researcher (ECR) who wants to delve into drug repurposing?   Join us for the third REMEDi4ALL Hackathon, 6-11 September 2026, held at Hotel Checkin Montserrat,...

The Hungarian Health Economics Association (META) is pleased to invite patients, carers, patient organisation representatives, clinicians, HTA professionals and other interested stakeholders to its next online webinar. The participation of...

A study that is suitable for publication or guideline development is not automatically suitable for marketing authorisation. Hellen Houlleberghs, Orfenix’ s clinical director will discuss what changes when the goal...

On 5 November 2026, the Global Pharmaceutical and Society Studies (GPSS) Network will run a closed, interactive workshop with 50 participants under Chatham House rules at the Humanity Hub, The Hague, the...

Join the REMEDi4ALL Repurposing Bootcamp and lead the way in innovative treatment strategies. The REMEDi4ALL Repurposing Bootcamp is a specialised training programme designed to empower patient representatives with the essential knowledge and...

As in previous editions,  #iDR27 will feature a pre-conference meeting dedicated to the REMEDi4ALL Funders Network on Monday 14 June.  More information about this event, including a link to the registration form, will...

Join the leading international drug repurposing conference by REMEDi4ALL and Beacon for Rare Diseases to explore how we can move promising science, ideas, and collaborations further towards patient impact.  #iDR27...